Physician profile
Katherine Sladewski
NPI 1104481324
$5,182.43
in general payments reported to CMS, 2019-2025
35 companies · $1,177 in 2025
The $1,177 reported for 2025 was more than what 86% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $820 · 2022: $909 · 2023: $998 · 2024: $1,279 · 2025: $1,177.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,276 · Education: $178.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,276.04 |
| Education | $177.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,053.09 | 2022-2025 | |
| Sumitomo Pharma America, INC. | $522.95 | 2023-2025 | Gemtesa, Orgovyx |
| Astellas Pharma US INC | $516.98 | 2021-2025 | Xtandi |
| Dendreon Pharmaceuticals LLC | $419.90 | 2021-2025 | Provenge |
| Urogen Pharma, INC. | $325.12 | 2022-2025 | Jelmyto |
| Myriad Genetic Laboratories, INC. | $214.73 | 2022-2024 | Prolaris, Myrisk |
| Teleflex LLC | $210.54 | 2022-2025 | Solesta, Urolift |
| Bayer Healthcare Pharmaceuticals INC. | $205.11 | 2022-2025 | |
| Progenics Pharmaceuticals, INC. | $204.56 | 2021-2025 | Pylarify |
| Urovant Sciences INC | $197.24 | 2022 | |
| Merck Sharp & Dohme LLC | $155.68 | 2022-2025 | Keytruda, Lynparza, Welireg |
| Acerus Pharmaceuticals Corporation | $144.25 | 2021-2022 | |
| Myovant Sciences INC. | $142.97 | 2021-2022 | |
| Axonics, INC. | $115.06 | 2024 | Axonics |
| Boston Scientific Corporation | $86.00 | 2022-2025 | Axonics, Solyx Sis System |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Blue Earth Diagnostics | $80.78 | 2021-2023 | |
| Telix Pharmaceuticals | $76.98 | 2024-2025 | Illuccix |
| Tolmar Pharmaceuticals, INC. | $53.01 | 2021 | |
| Pfizer INC. | $48.47 | 2025 | |
| Otsuka America Pharmaceutical, INC. | $47.20 | 2021 | |
| Ferring Pharmaceuticals INC. | $39.45 | 2025 | Adstiladrin |
| Antares Pharma, INC. | $35.32 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $29.92 | 2023 | Lynparza |
| Hollister Incorporated | $29.65 | 2023 | Infyna Chic, Vapro |
| 180 Medical, INC. | $28.51 | 2023 | |
| Janssen Biotech, INC. | $26.04 | 2024 | Erleada |
| Amgen INC. | $25.88 | 2022 | |
| Procept Biorobotics Corporation | $25.84 | 2025 | |
| Immunitybio, INC. | $24.36 | 2025 | |
| Tolmar, INC. | $21.00 | 2024 | |
| Smith+Nephew, INC. | $18.01 | 2021 | |
| Calyxo, INC. | $16.20 | 2024 | Cvac Aspiration System |
| Millicent US INC | $15.29 | 2024 | Femring, Intrarosa |
| Stryker Corporation | $14.52 | 2023 | Fluid Management System |
| Agiliti Surgical, INC. | $11.82 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katherine Sladewski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.